Mostrar el registro sencillo del ítem

dc.contributor.advisorAraújo Reyes, Ana Teresa
dc.contributor.advisorMantilla Suárez, Juan Carlos
dc.contributor.advisorUribe Caputi, Juan Carlos
dc.contributor.authorRey Ayala, Milena
dc.coverage.spatialBucaramanga (Santander, Colombia)spa
dc.coverage.temporal2022spa
dc.date.accessioned2023-03-01T16:37:40Z
dc.date.available2023-03-01T16:37:40Z
dc.date.issued2022
dc.identifier.urihttp://hdl.handle.net/20.500.12749/19154
dc.description.abstractIntroducción: Las hiperintensidades de sustancia blanca son cada vez un hallazgo más frecuente en las resonancias magnéticas cerebrales y han sido descritas en numerosas patologías. Su diagnóstico diferencial dependerá de la localización, morfología y comportamiento en el tiempo y en las diferentes secuencias obtenidas. Algunos autores han encontrado asociación entre este hallazgo en resonancia magnética y la migraña, pudiendo ser explicado por los cambios de la microvasculatura cerebral. Sin embargo, no todos los textos concuerdan en esto, muchos autores no han encontrado asociación estadísticamente significativa entre estas dos patologías. Por tanto el objetivo del presente estudio es establecer la asociación entre el diagnóstico de migraña y las hiperintensidades de sustancia blanca en la resonancia magnética de pacientes menores de 50 años con impresión diagnóstica de cefalea en un centro radiológico de referencia en Bucaramanga. Metodología: Se realizó un estudio analítico transversal en pacientes con cefalea que asistían a la toma de resonancia magnética cerebral de nuestra institución entre enero del 2022 y junio del 2022. Se incluyeron todos los pacientes menores de 50 años que aceptaron la participación en el estudio y se excluyeron aquellos pacientes con factores de riesgo cardiovascular como diabetes mellitus o hipertensión arterial y aquellos con enfermedad de sustancia blanca ya establecida. Resultados: Durante el periodo establecido se incluyeron 70 pacientes con migraña y 39 pacientes con otras cefaleas primarias, con edades comprendidas entre los 19 años y 49 años. La incidencia de las hiperintensidades de sustancia blanca fue de 42%. Los pacientes con hiperintensidades de sustancia blanca tenían mayor edad que aquellos que no las presentaban (35.2 años vs 31.5 años p 0.02). En el presente estudio no encontró asociación estadísticamente significativas entre la presencia de migraña e hiperintensidades de la sustancia blanca en resonancia magnética, así como tampoco con el resto de variables estudiadas incluyendo la presencia o no de aura, edad, localización, grado de severidad clínica ni radiológica. Conclusión: No se logró encontrar asociación entre las hiperintensidades de sustancia blanca y la migraña ni con las otras variables clínicas ni radiológicas a diferencia de otros estudios publicados en la literatura, por tanto, es necesario realizar estudios con mayor tamaño de muestral en nuestra población para aclarar la asociación entre estas dos entidades.spa
dc.description.tableofcontents1. RESUMEN 2. PLANTEAMIENTO DEL PROBLEMA Y JUSTIFICACIÓN 3. MARCO TEÓRICO 4. ESTADO DEL ARTE 5. OBJETIVOS 5.1 Objetivo General 5.2 Objetivos Específicos 6 METODOLOGÍA 6.1 Tipo de estudio 6.2 Población y muestra 6.3 Criterios de inclusión y exclusión 6.4 Variables del estudio 7 PROCEDIMIENTO 8 DEPURACIÓN DE DATOS Y PLAN DE ANÁLISIS 9 CONSIDERACIONES ÉTICAS 10 CRONOGRAMA DE ACTIVIDADES 11 RESULTADOS 12 DISCUSIÓN 13 CONCLUSIÓN 14 REFERENCIAS BIBLIOGRÁFICAS 15 ANEXOSspa
dc.format.mimetypeapplication/pdfspa
dc.language.isospaspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.titleHiperintensidades de sustancia blanca en pacientes con migrañaspa
dc.title.translatedWhite matter hyperintensities in patients with migrainespa
dc.degree.nameEspecialistas en Radiología e Imágenes Diagnósticasspa
dc.publisher.grantorUniversidad Autónoma de Bucaramanga UNABspa
dc.rights.localAbierto (Texto Completo)spa
dc.publisher.facultyFacultad Ciencias de la Saludspa
dc.publisher.programEspecialización en Radiología e Imágenes Diagnósticasspa
dc.description.degreelevelEspecializaciónspa
dc.type.driverinfo:eu-repo/semantics/masterThesis
dc.type.localTesisspa
dc.type.coarhttp://purl.org/coar/resource_type/c_bdcc
dc.subject.keywordsMedical sciencesspa
dc.subject.keywordsHealth sciencesspa
dc.subject.keywordsRadiologyspa
dc.subject.keywordsDiagnostic imagingspa
dc.subject.keywordsWhite matter hyperintensitiesspa
dc.subject.keywordsMigrainespa
dc.subject.keywordsPatientspa
dc.subject.keywordsMagnetic resonance imagingspa
dc.subject.keywordsCephalalgiaspa
dc.subject.keywordsDemographic characteristicsspa
dc.subject.keywordsImaging systems in medicinespa
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga - UNABspa
dc.identifier.reponamereponame:Repositorio Institucional UNABspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.relation.references1. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010 Jul 26;341:c3666.spa
dc.relation.references2. Forbes K. MRI brain white matter change: spectrum of change – how can we grade?. Journal of the Royal College of Physicians of Edinburgh. 2017;47(3):271-275.spa
dc.relation.referencesForbes K. MRI brain white matter change: spectrum of change – how can we grade?. Journal of the Royal College of Physicians of Edinburgh. 2017;47(3):271-275.spa
dc.relation.referencesWoldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: A systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci. 2017;372:307-315.spa
dc.relation.references5. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017;390:1211- 59.spa
dc.relation.references6. Lee M, Moon S, Chung C. White matter hyperintensities in migraine: a review. Precision and Future Medicine. 2019;3(4):146-157.spa
dc.relation.references7. Fazekas F, Koch M, Schmidt R, Offenbacher H, Payer F, Freidl W, Lechner H. The prevalence of cerebral damage varies with migraine type: a MRI study. Headache. 1992;32(6):287-91.spa
dc.relation.references8. Uggetti C, Squarza S, Longaretti F, Galli A, Di Fiore P, Reganati PF, Campi A, Ardemagni A, Cariati M, Frediani F. Migraine with aura and white matter lesions: an MRI study. Neurol Sci. 2017;38(Suppl 1):11-13spa
dc.relation.references9. Lee MJ, Park BY, Cho S, Park H, Chung CS. Cerebrovascular reactivity as a determinant of deep white matter hyperintensities in migraine. Neurology. 2019;92(4):e342-e350.spa
dc.relation.references10. Xie H, Zhang Q, Huo K, Liu R, Jian ZJ, Bian YT, Li GL, Zhu D, Zhang LH, Yang J, Luo GG. Association of white matter hyperintensities with migraine features and prognosis. BMC Neurol. 2018 Jul 2;18(1):93.e342-e350.spa
dc.relation.references11. Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, Launer LJ. Migraine as a risk factor for subclinical brain lesions. JAMA. 2004 Jan 28;291(4):427-34.spa
dc.relation.references12. Rodríguez L. Prevalencia de enfermedad cerebral de pequeño vaso y sus características imagenológicas en una población mayor de 40 años. Repositorio UNAB. 2019. aine as a risk factor for subclinical brain lesions. JAMA. 2004 Jan 28;291(4):427-34.spa
dc.relation.referencesHeadache [Internet]. Mayo Clinic. 2021 [citado 25 Julio 2021]. Disponible en: https://www.mayoclinic.org/symptoms/headache/basics/definition/sym-20050800?reDate=13072021spa
dc.relation.references14. Latinovic R, Gulliford M, Ridsdale L. Headache and migraine in primary care: consultation, prescription, and referral rates in a large population. J Neurol Neurosurg Psychiatry. 2006 Mar;77(3):385-7.spa
dc.relation.references15. Stovner LJ, Hagen K, Linde M, Steiner TJ. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J Headache Pain. 2022 Apr 12;23(1):34.spa
dc.relation.references16. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018, 38(1), 1-211.spa
dc.relation.references17. Rizzoli, P., & Mullally, W. J. (2018). Headache. The American Journal of Medicine, 131(1), 17–24.gia. 2018, 38(1), 1-211.spa
dc.relation.references18. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015, Lancet Neurol. 2017;16(11):877.spa
dc.relation.references19. Holle D, Obermann M. The role of neuroimaging in the diagnosis of headache disorders. Therapeutic Advances in Neurological Disorders. 2013;6(6):369-374.spa
dc.relation.referencesExpert Panel on Neurologic Imaging, Whitehead MT, Cardenas AM, Corey AS, Policeni B, Burns J, Chakraborty S, Crowley RW, Jabbour P, Ledbetter LN, Lee RK, Pannell JS, Pollock JM, Powers WJ, Setzen G, Shih RY, Subramaniam RM, Utukuri PS, Bykowski J. ACR Appropriateness Criteria Headache. J Am Coll Radiol. 2019;16(11S):S364-S377spa
dc.relation.referencesStovner LJ, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27:193-210.spa
dc.relation.references22. Migraine — Level 4 cause [Internet]. Institute for Health Metrics and Evaluation. 2019 [Citado 25 julio 2021]. Disponible en: http://www.healthdata.org/results/gbd_summaries/2019/migraine-level-4-causspa
dc.relation.references24. Pradilla A. G, Vesga A. B, León-Sarmiento F. Estudio neuroepidemiológico nacional (EPINEURO) colombiano. Revista Panamericana de Salud Pública. 2003;14(2):104-111.spa
dc.relation.references23. Pradilla G, Pardo C, Zuñiga A, Daza J. Estudios neuroepidemiológicos colombianos empleando el protocolo de la OMS. Rev Neurol Argent 1994; 19: 9-14.spa
dc.relation.references25. Rueda-Sánchez M, Díaz-Martínez LA. Prevalence and associated factors for episodic and chronic daily headache in the Colombian population. Cephalalgia. 2008;28(3):216-25.spa
dc.relation.referencesBecker WJ, Findlay T, Moga C, Scott A, Harstall C, Taenzer P. Guideline for primary care management of headache in adults. Canadian Family Physician. 2015;61.spa
dc.relation.referencesFrishberg B, Rosenberg J, Matchar D, Mccoroy D. Evidence-Based Guidelines in the Primary Care Setting: Neuroimaging in Patients with Nonacute Headache. American Academy of Neurology. 2000.spa
dc.relation.references28. Katz M. The cost-effective evaluation of uncomplicated headache. Med Clin North Am 2016;100:1009-17.spa
dc.relation.references29. Bashir A, Lipton RB, Ashina S, Ashina M. Migraine and structural changes in the brain: a systematic review and meta-analysis. Neurology. 2013;81(14):1260-8spa
dc.relation.references30. Porter A, Gladstone JP, Dodick DW. Migraine and white matter hyperintensities. Curr Pain Headache Rep. 2005;9(4):289-93spa
dc.relation.references31. Hamedani A, Rose K, Peterlin B, Mosley T, Coker L, Jack C, Knopman D, Alonso A, Gottesman R. Migraine and white matter hyperintensities: the ARIC MRI study. Neurology. 2013;81(15):1308–1313.spa
dc.relation.references32. Kurth T, Mohamed S, Maillard P, Zhu Y, et al. Headache, migraine, and structural brain lesions and function: population based Epidemiology of Vascular Ageing-MRI study. BMJ 2011; 342: c7357spa
dc.relation.references33. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12(5):483-97.spa
dc.relation.references34. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, et al. STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to aging and neurodegeneration. Lancet Neurol. 2013;12(8):822-38.spa
dc.relation.references35. Fazekas F. Magnetic resonance signal abnormalities in asymptomatic individuals: their incidence and functional correlates. Eur Neurol. 1989;29(3):164-8spa
dc.relation.references36. Oyama H, Kida Y, Tanaka T, Iwakoshi T, Niwa M, Kobayashi T. Incidental white matter lesions identified on magnetic resonance images of normal Japanese individuals--correlation with age and hypertension. Neurol Med Chir (Tokyo). 1994;34(5):286-90.spa
dc.relation.references37. Longstreth W, Manolio T, Arnold A, Burke G, Bryan N, Jungreis C et al. Clinical Correlates of White Matter Findings on Cranial Magnetic Resonance Imaging of 3301 Elderly People. Stroke. 1996;27(8):1274-1282.. Neurol Med Chir (Tokyo). 1994;34(5):286-90.spa
dc.relation.references38. Goadsby PJ. Migraine pathophysiology. Headache. 2005;45 Suppl 1:S14-24.spa
dc.relation.references39. Bednarczyk EM, Remler B, Weikart C, Nelson AD, Reed RC. Global cerebral blood flow, blood volume, and oxygen metabolism in patients with migraine headache. Neurology. 1998;50(6):1736-40spa
dc.relation.references40. Gozke E, Ore O, Dortcan N, Unal Z, Cetinkaya M. Cranial magnetic resonance imaging findings in patients with migraine. Headache. 2004;44(2):166-9.spa
dc.relation.references41. Zimmerman RD, Fleming CA, Lee BC, Saint-Louis LA, Deck MD. Periventricular hyperintensity as seen by magnetic resonance: prevalence and significance. AJR Am J Roentgenol. 1986;146(3):443-50.spa
dc.relation.references42. Rossato G, Adami A, Thijs VN, Cerini R, Pozzi-Mucelli R, Mazzucco S, Anzola GP, Del Sette M, Dinia L, Meneghetti G, Zanferrari C; SAM study group. Cerebral distribution of white matter lesions in migraine with aura patients. Cephalalgia. 2010;30(7):855-9.spa
dc.relation.references43. Kanekar S, Devgun P. A pattern approach to focal white matter hyperintensities on magnetic resonance imaging. Radiol Clin North Am. 2014;52(2):241-61.spa
dc.relation.references44. Gaillard, F. (s. f.). Fazekas scale for white matter lesions | Radiology Reference Article | Radiopaedia.org. Radiopaedia. Recuperado 13 de julio de 2021, de https://radiopaedia.org/articles/fazekas-scale-for-white-matter-lesionsspa
dc.relation.references45. El Hasnaoui A, Vray M, Blin P, Nachit-Ouinekh F, Boureau F; HEMISHERE study group. Assessment of migraine severity using the MIGSEV scale: relationship to migraine features and quality of life. Cephalalgia. 2004;24(4):262-70spa
dc.relation.references46. El Hasnaoui A, Vray M, Richard A, Nachit-Ouinekh F, Boureau F; MIGSEV Group. Assessing the severity of migraine: development of the MIGSEV scale. Headache. 2003;43(6):628-35.spa
dc.relation.references47. Negm M, Housseini AM, Abdelfatah M, Asran A. Relation between migraine pattern and white matter hyperintensities in brain magnetic resonance imaging. Egypt J Neurol Psychiatr Neurosurg. 2018;54(1):24.spa
dc.relation.references48. Palm-Meinders IH, Koppen H, Terwindt GM, Launer LJ, Konishi J, Moonen JM, Bakkers JT, Hofman PA, van Lew B, Middelkoop HA, van Buchem MA, Ferrari MD, Kruit MC. Structural brain changes in migraine. JAMA. 2012;308(18):1889-97.spa
dc.relation.references48. Palm-Meinders IH, Koppen H, Terwindt GM, Launer LJ, Konishi J, Moonen JM, Bakkers JT, Hofman PA, van Lew B, Middelkoop HA, van Buchem MA, Ferrari MD, Kruit MC. Structural brain changes in migraine. JAMA. 2012;308(18):1889-97.spa
dc.relation.references50. Monteith T, Gardener H, Rundek T, Dong C, Yoshita M, Elkind MS, DeCarli C, Sacco RL, Wright CB. Migraine, white matter hyperintensities, and subclinical brain infarction in a diverse community: the northern Manhattan study. Stroke. 2014;45(6):1830-2.spa
dc.relation.references51. Igarashi, H., Sakai, F., Kan, S., Okada, J., & Tazaki, Y. Magnetic Resonance Imaging of The Brain in Patients With Migraine. Cephalalgia. 1991;11(2), 69–74.spa
dc.relation.references52. Pavese, N., Canapicchi, R., Nuti, A., Bibbiani, F., Lucetti, C., Collavoli, P., & Bonuccelli, U. White Matter MRI Hyperintensities in a Hundred and Twenty-Nine Consecutive Migraine Patients. Cephalalgia. 1994; 14(5), 342–345.Brain in Patients With Migraine. Cephalalgia. 1991;11(2), 69–74.spa
dc.relation.references54. Meilán, A., Larrosa, D., Ramón, C., Cernuda‐Morollón, E., Martínez‐Camblor, P., Saiz, A., … Pascual, J. No association between migraine frequency and white matter lesions and silent brain infarctions: a study in a series of chronic migraine women. European Journal of Neurology. 2020, 0: 1–8spa
dc.relation.references53. Swartz RH, Kern RZ. Migraine Is Associated With Magnetic Resonance Imaging White Matter Abnormalities: A Meta-analysis. Arch Neurol. 2004;61(9):1366–1368.spa
dc.relation.references55. Le Pira F, Reggio E, Quattrocchi G, Sanfilippo C, Maci T, Cavallaro T, Zappia M. Executive dysfunctions in migraine with and without aura: what is the role of white matter lesions? Headache. 2013;54(1):125–130.spa
dc.relation.references56. Seneviratne U, Chong W, Billimoria P. Brain white matter hyperintensities in migraine: clinical and radiological correlates. Clin Neurol Neurosurg. 2013;115(7):1040–1043.spa
dc.relation.references57. Ahmed SR, Mohamed AAM, Salem HH, Helmy S, Moustafa RR, Borham SMF. Association of white matter hyperintensities with migraine phenotypes and response to treatment. Acta Neurol Belg. 2022 Jul 19.spa
dc.relation.references58. Onay M, Yıldoğan AT, Eren F. Relationship between headache, corpus callosum, and deep white matter lesions in patients with migraine. Cukurova Med J. 2022;47(1):436-445spa
dc.relation.references59. Toghae M, Rahimian E, Abdollahi M, Shoar S, Naderan M. The prevalence of magnetic resonance imaging Hyperintensity in migraine patients and its association with migraine headache characteristics and cardiovascular risk factors. Oman Med J. 2015;30(3):203–207.spa
dc.relation.references60. Zhang Q, Datta R, Detre J, Cucchiara B. White matter lesion burden in migraine with aura may be associated with reduced cerebral blood flow. Cephalalgia. 2016;37(6):517–524.spa
dc.relation.references61. Trauninger A, Leél-Őssy E, Kamson D, Pótó L, Aradi M, Kövér F, Imre M, Komáromy H, Erdélyi-Botor S, Patzkó Á, Pfund Z. Risk factors of migraine-related brain white matter hyperintensities: an investigation of 186 patients. J Headache Pain. 2011;12(1):97–103.spa
dc.relation.references62. Kruit M, van Buchem M, Launer L, Terwindt G, Ferrari M. Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia. 2010;30(2):129–136.spa
dc.relation.references63. Rothwell P. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet. 2010;375(9718):938–948.spa
dc.relation.references64. Cooney, B. S., Grossman, R. I., Farber, R. E., Goin, J. E., & Galetta, S. L. (1996). Frequency of magnetic resonance imaging abnormalities in patients with migraine. Headache: The Journal of Head and Face Pain, 36(10), 616–621.spa
dc.relation.references65. Gomez-Beldarrain M, Oroz I, Zapirain B, Ruanova B, Fernandez Y, Cabrera A, Anton-Ladislao A, Aguirre-Larracoechea U, Garcıa-Monco J. Right fronto-insular white matter tracts link cognitive reserve and pain in migraine patients. J Headache Pain. 2016;17(1):4.spa
dc.relation.references66. Chong C, Schwedt T. Migraine affects white-matter tract integrity: a diffusion-tensor imaging study. Cephalalgia. 2015;35(13):1162–1171.spa
dc.contributor.cvlacAraújo Reyes, Ana Teresa [0000117925]spa
dc.contributor.cvlacMantilla Suárez, Juan Carlos [0001482827]spa
dc.contributor.cvlacUribe Caputi, Juan Carlos [0001435212]spa
dc.contributor.googlescholarUribe Caputi, Juan Carlos Alberto [z6reFf8ZcCwC]spa
dc.contributor.orcidUribe Caputi, Juan Carlos Alberto [0000-0002-4971-339X]spa
dc.contributor.researchgateUribe Caputi, Juan Carlos Alberto [Juan_Uribe-Caputi]spa
dc.subject.lembCiencias médicasspa
dc.subject.lembRadiologíaspa
dc.subject.lembDiagnóstico para imágenesspa
dc.subject.lembResonancia magnéticaspa
dc.subject.lembCefalalgiaspa
dc.subject.lembCaracterísticas demográficasspa
dc.subject.lembSistemas de imágenes en medicinaspa
dc.identifier.repourlrepourl:https://repository.unab.edu.cospa
dc.description.abstractenglishIntroduction: White matter hyperintensities are an increasingly frequent finding in brain magnetic resonance imaging and have been described in numerous pathologies. Its differential diagnosis will depend on the location, morphology and behavior over time and on the different sequences obtained. Some authors have found an association between this finding in magnetic resonance imaging and migraine, which can be explained by changes in the cerebral microvasculature. However, not all texts agree on this, many authors have not found a statistically significant association between these two pathologies. Therefore, the objective of this study is to establish the association between the diagnosis of migraine and white matter hyperintensities in magnetic resonance imaging of patients under 50 years of age with a diagnostic impression of headache at a reference radiological center in Bucaramanga. Methodology: A cross-sectional analytical study was carried out in patients with headache who attended the brain magnetic resonance at our institution between January 2022 and June 2022. All patients under 50 years of age who agreed to participate in the study was included and patients with cardiovascular risk factors such as diabetes mellitus or arterial hypertension and those with already established white matter disease were excluded. Results: During the established period, 70 patients with migraine and 39 patients with other primary headaches, aged between 19 and 49 years, were included. The incidence of white matter hyperintensities was 42%. Patients with white matter hyperintensities were older than those who did not present them (35.2 years vs 31.5 years p 0.02). In the present study, no statistically significant association was found between the presence of migraine and white matter hyperintensities in magnetic resonance, neither with the rest of the variables studied, including the presence or absence of aura, age, location, degree of clinical severity or radiological. Conclusion: It was not possible to find an association between white matter hyperintensities and migraine or with other clinical or radiological variables, unlike other studies published in the literature, therefore, it is necessary to carry out studies with a larger sample in our population to clarify the association between these two entities.spa
dc.subject.proposalCiencias de la saludspa
dc.subject.proposalHiperintensidades de sustancia blancaspa
dc.subject.proposalMigrañaspa
dc.subject.proposalPacientespa
dc.type.redcolhttp://purl.org/redcol/resource_type/TM
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 2.5 Colombia*
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.relation.uriapolohttps://apolo.unab.edu.co/en/persons/juan-carlos-alberto-uribe-caputispa
dc.contributor.apolounabUribe Caputi, Juan Carlos [juan-carlos-alberto-uribe-caputi]spa
dc.coverage.campusUNAB Campus Bucaramangaspa
dc.description.learningmodalityModalidad Presencialspa


Ficheros en el ítem

Thumbnail
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-SinDerivadas 2.5 Colombia
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 2.5 Colombia